Page 3 - Profoundbio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genmab Buys Ovarian Cancer Drug Developer ProfoundBio for $1 8 Billion

Genmab Buys Ovarian Cancer Drug Developer ProfoundBio for $1 8 Billion
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Profoundbio inc

Genmab A/S (GMAB) to Acquire ProfoundBio for $1 8B Cash

Genmab A/S (GMAB) to Acquire ProfoundBio for $1 8B Cash
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Baiteng zhaoKromann reumertTravers thorp albergaMorgan stanley coBofa securities incCompany announcementGoldman sachs internationalProfoundbio incShearman sterlingDrug administrationFast trackChief executive officerSachs internationalMorgan stanleyJun he law offices

Genmab A/S: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

Genmab A/S: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyAndrew carlsenMarisol peronKromann reumertBaiteng zhaoTravers thorp albergaDennis riedlBofa securities incProfoundbio incMorgan stanley coDrug administrationCompany announcementGlobal communications corporate affairsShearman sterlingExchange commission

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

Company Announcement Genmab to acquire ProfoundBio for USD 1.8 billion in cash Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart.

New jerseyUnited statesTravers thorp albergaKromann reumertAndrew carlsenBaiteng zhaoMarisol peronGlobal communications corporate affairsShearman sterlingGoldman sachs internationalBofa securities incCompany announcementProfoundbio incMorgan stanley coDrug administrationExchange commission

Genmab Buys Ovarian Cancer Drug Developer for $1 8 Billion

Genmab Buys Ovarian Cancer Drug Developer for $1 8 Billion
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Profoundbio rinaSoren lontoft hansenProfoundbio incRoche holdingAbbvie incPfizer incAstrazeneca plcImmunogen incLontoft hansen